{
  "id": "601eab7d1cb411341a000053",
  "type": "factoid",
  "question": "What class of drugs have been given a black box warning for suicide?",
  "ideal_answer": "In 2004, the European and American authorities released a black-box warning on antidepressants indicating an association with an increased risk of suicidality (suicidal ideation and behavior) in young people",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31130881",
    "http://www.ncbi.nlm.nih.gov/pubmed/19488000",
    "http://www.ncbi.nlm.nih.gov/pubmed/26149466",
    "http://www.ncbi.nlm.nih.gov/pubmed/24696870",
    "http://www.ncbi.nlm.nih.gov/pubmed/20222492",
    "http://www.ncbi.nlm.nih.gov/pubmed/23109125",
    "http://www.ncbi.nlm.nih.gov/pubmed/21903028",
    "http://www.ncbi.nlm.nih.gov/pubmed/20011576",
    "http://www.ncbi.nlm.nih.gov/pubmed/19996040",
    "http://www.ncbi.nlm.nih.gov/pubmed/31136275",
    "http://www.ncbi.nlm.nih.gov/pubmed/17074941",
    "http://www.ncbi.nlm.nih.gov/pubmed/25345238",
    "http://www.ncbi.nlm.nih.gov/pubmed/32587531",
    "http://www.ncbi.nlm.nih.gov/pubmed/32116839",
    "http://www.ncbi.nlm.nih.gov/pubmed/17914327"
  ],
  "snippets": [
    {
      "text": "The FDA \"Black Box\" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefit",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31130881",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31130881",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " However, within the past decade, an increasing number of reports have questioned the actual validity of the FDA warning, especially considering a decline in the prescription of the antidepressant drugs associated with an increase in the rate of suicidal events among people with severe depression",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31130881",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": ". In 2004, the European and American authorities released a black-box warning on antidepressants indicating an association with an increased risk of suicidality (suicidal ideation and behavior) in young people",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31136275",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In 2004, the US Food and Drug Administration (FDA) controversially issued a black box warning that antidepressants were associated with an increased risk of suicidal thoughts and behaviours in people aged under 18 years. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32587531",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The United States Food and Drug Administration issued a Black Box warning in October 2004 after placebo-controlled trials of antidepressant medications found an increased risk of suicidal thoughts and behaviors among children and adolescents taking antidepressant medications relative to placebo.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32116839",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Subsequently, some researchers have concluded that the Black Box warning caused severe unintended consequences; specifically, they have argued that the warning led to reduced use of antidepressants among youth, which led to more suicides",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32116839",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: Isotretinoin (13-cis-retinoic acid), approved by the US Food and Drug Administration for the treatment of acne, carries a black box warning related to the risk of depression, suicide, and psychosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21903028",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "There has been a decrease in the use of antidepressant therapy in children and adolescents following the US Food and Drug Administration black box warning for risk of suicide.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20011576",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This study evaluates changes in use of antidepressants in children and adolescents after the US Food and Drug Administration black box warning for increased risk of suicide.Method.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20011576",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Subsequently, some researchers have concluded that the Black Box warning caused severe unintended consequences; specifically, they have argued that the warning led to reduced use of antidepressants among youth, which led to more suicides.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32116839",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The FDA \"Black Box\" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31130881",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "On July 10, 2008, a Food and Drug Administration scientific advisory committee voted that, yes, there was a significant positive association between AEDs and suicidality but voted against placing a black box warning on AEDs for suicidality.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19996040",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32116839",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Food and Drug Administration has recently introduced the so-called \"black box\" on antidepressants' packages with the aim of gaining attention to the possible risk of suicide among adolescents who are treated with antidepressants, with a warning that the risk of suicide is higher when starting a therapy or while adjusting its dosage.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26149466",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: Isotretinoin (13-cis-retinoic acid), approved by the US Food and Drug Administration for the treatment of acne, carries a black box warning related to the risk of depression, suicide, and psycho",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21903028",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In 2004 the Food and Drug Administration (FDA) issued a \"black-box\" warning for antidepressants in children and adolescents, stating that these drugs may increase suicidality, a term encompassing both suicidal thoughts and behavior, especially in the first few weeks of treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25345238",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The US FDA has required that antidepressants carry a black box warning that there may be a risk of suicidal ideations in depressed pediatric patients treated with these medications, and recently extended the warning to include individuals up age 24.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19488000",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES: To study prescribing trends for antidepressants in Hawai'i following the FDA black box warning regarding the possible risk of suicide in children and adolescents.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20222492",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The FDA recently linked adverse event reports of suicidal ideation among children and adolescents in randomized controlled trials to selective serotonin reuptake inhibitors (SSRIs) and consequently required a change in labeling that included a black box warning regarding SSRI use for all age groups.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17074941",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Another hurdle faced by new drugs is the requirement that all antidepressants carry a black-box warning regarding the increased risk of suicide in children, adolescents and young adults, which limits their use in this population.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24696870",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The quality of studies regarding the psychopharmacological therapy of depressive disorders in childhood and adolescence has improved since the \u00abblack box\u00bb warning of the FDA concerning the occurrence of suicidality under treatment with selective serotonin reuptake inhibitors (SSRIs).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23109125",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults still represents a matter of controversy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31130881",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To study prescribing trends for antidepressants in Hawai'i following the FDA black box warning regarding the possible risk of suicide in children and adolescents.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20222492",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Regulatory agencies of different European countries and the United States have been critically examining the possible link between suicidality and antidepressant use in children and adults, which has resulted in an FDA directive to the manufacturers of all antidepressant medications to add a 'black box' warning.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17914327",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: Isotretinoin (13-cis-retinoic acid), approved by the US Food and Drug Administration for the treatment of acne, carries a black box warning related to the risk of depression, suicide, and",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21903028",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "anti-depressants, selective serotonin reuptake inhibitors, SSRIs"
}